2/22/2024  5:35:16 PM Chg. +2.25 Volume Bid5:35:16 PM Ask2/22/2024 Market Capitalization Dividend Y. P/E Ratio
112.50EUR +2.04% 122,017
Turnover: 13.71 mill.
-Bid Size: - -Ask Size: - 10.06 bill.EUR 0.98% 34.62

Business description

Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The Company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of ZEISS is rounded off by promising future technologies such as intraoperative radiation therapy.
 

Management board & Supervisory board

CEO
Dr. Markus Weber
Management board
Justus Felix Wehmer
Supervisory board
Dr. Karl Lamprecht, Isabel De Paoli, Tanja von der Goltz, Peter Kameritsch, Dr. Christian Müller, Torsten Reitze, Renè Denner, Brigitte Koblizek, Jeffrey Marx , Heike Madan, Falk Bindheim, Dr. Christian Münster
 

Company data

Name: Carl Zeiss Meditec AG
Address: Göschwitzer Straße 51-52,D-07745 Jena
Phone: +49-3641-220-0
Fax: +49 3641 220 112
E-mail: info@meditec.zeiss.com
Internet: zeiss.de/corporate/home.html
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 9/30
Free Float: 40.90%
IPO date: 3/22/2000

Investor relations

Name: Sebastian Frericks
IR phone: +49-3641-220-116
IR Fax: +49-3641-220-117
IR e-mail: investors.meditec@zeiss.com

Company calendar

CW 12 | 3/20/2024 Ex-Dividend
CW 12 | 3/21/2024 General Shareholder Meeting
CW 12 | 3/22/2024 Dividend Payment
CW 19 | 5/8/2024 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Carl Zeiss AG und Carl Zeiss Inc.
 
59.14%
Others
 
40.86%